On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Risk of Transfusion-Transmitted Babesiosis” guidance document with a maximum 12 month implementation timeline. Per the FDA guidance document recommendations, CTS is developing a specific implementation plan for mandatory Babesia testing well before the May 8, 2020 deadline.
Check out the Communication page for the complete details by clicking the link: Communications
Josh Moon has been appointed Chief Operating Officer (COO) at Creative Testing Solutions (CTS), effe...
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor anti...
Through communications with our clients, CTS is aware of the current national blood shortage. We rea...
In 2016, the Procleix Panther instrument was introduced by Grifols in support of automated NAT ZIKA ...
As a friendly reminder, airlines often change their routine flights and cargo hours for hol...